Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,654 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Novel tethers in ketolide antibiotics.
Kaneko T, Romero K, Li B, Buzon R. Kaneko T, et al. Bioorg Med Chem Lett. 2007 Sep 15;17(18):5049-53. doi: 10.1016/j.bmcl.2007.07.018. Epub 2007 Jul 13. Bioorg Med Chem Lett. 2007. PMID: 17659873
Discovery of azetidinyl ketolides for the treatment of susceptible and multidrug resistant community-acquired respiratory tract infections.
Magee TV, Ripp SL, Li B, Buzon RA, Chupak L, Dougherty TJ, Finegan SM, Girard D, Hagen AE, Falcone MJ, Farley KA, Granskog K, Hardink JR, Huband MD, Kamicker BJ, Kaneko T, Knickerbocker MJ, Liras JL, Marra A, Medina I, Nguyen TT, Noe MC, Obach RS, O'Donnell JP, Penzien JB, Reilly UD, Schafer JR, Shen Y, Stone GG, Strelevitz TJ, Sun J, Tait-Kamradt A, Vaz AD, Whipple DA, Widlicka DW, Wishka DG, Wolkowski JP, Flanagan ME. Magee TV, et al. Among authors: kaneko t. J Med Chem. 2009 Dec 10;52(23):7446-57. doi: 10.1021/jm900729s. J Med Chem. 2009. PMID: 19775168
Synthesis and SAR of novel conformationally-restricted oxazolidinones possessing gram-positive and fastidious gram-negative antibacterial activity. Part 1: Substituted pyrazoles.
Boyer FE, Vara Prasad JV, Choy AL, Chupak L, Dermyer MR, Ding Q, Huband MD, Jiao W, Kaneko T, Khlebnikov V, Kim JY, Lall MS, Maiti SN, Romero K, Wu X. Boyer FE, et al. Among authors: kaneko t. Bioorg Med Chem Lett. 2007 Aug 15;17(16):4694-8. doi: 10.1016/j.bmcl.2007.05.056. Epub 2007 May 24. Bioorg Med Chem Lett. 2007. PMID: 17590334
Drugs for neglected diseases: part I.
Kaneko T. Kaneko T. Future Med Chem. 2011 Aug;3(10):1235-7. doi: 10.4155/fmc.11.103. Future Med Chem. 2011. PMID: 21859296 No abstract available.
Tuberculosis drug discovery and emerging targets.
Mdluli K, Kaneko T, Upton A. Mdluli K, et al. Among authors: kaneko t. Ann N Y Acad Sci. 2014 Sep;1323:56-75. doi: 10.1111/nyas.12459. Epub 2014 Jun 11. Ann N Y Acad Sci. 2014. PMID: 24920100 Review.
Drugs for neglected diseases: part II.
Kaneko T. Kaneko T. Future Med Chem. 2011 Sep;3(11):1329-30. doi: 10.4155/fmc.11.104. Future Med Chem. 2011. PMID: 21879837 No abstract available.
Identification and optimization of a new series of anti-tubercular quinazolinones.
Couturier C, Lair C, Pellet A, Upton A, Kaneko T, Perron C, Cogo E, Menegotto J, Bauer A, Scheiper B, Lagrange S, Bacqué E. Couturier C, et al. Among authors: kaneko t. Bioorg Med Chem Lett. 2016 Nov 1;26(21):5290-5299. doi: 10.1016/j.bmcl.2016.09.043. Epub 2016 Sep 16. Bioorg Med Chem Lett. 2016. PMID: 27671498
4,654 results